Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients

Detalles Bibliográficos
Autores principales: Bacsur, Péter, Farkas, Klaudia, Molnar, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228885/
https://www.ncbi.nlm.nih.gov/pubmed/34792132
http://dx.doi.org/10.1093/ecco-jcc/jjab207
_version_ 1784734592663552000
author Bacsur, Péter
Farkas, Klaudia
Molnar, Tamás
author_facet Bacsur, Péter
Farkas, Klaudia
Molnar, Tamás
author_sort Bacsur, Péter
collection PubMed
description
format Online
Article
Text
id pubmed-9228885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92288852022-06-28 Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients Bacsur, Péter Farkas, Klaudia Molnar, Tamás J Crohns Colitis Letters to the Editor Oxford University Press 2021-11-18 /pmc/articles/PMC9228885/ /pubmed/34792132 http://dx.doi.org/10.1093/ecco-jcc/jjab207 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Bacsur, Péter
Farkas, Klaudia
Molnar, Tamás
Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title_full Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title_fullStr Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title_full_unstemmed Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title_short Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
title_sort outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228885/
https://www.ncbi.nlm.nih.gov/pubmed/34792132
http://dx.doi.org/10.1093/ecco-jcc/jjab207
work_keys_str_mv AT bacsurpeter outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients
AT farkasklaudia outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients
AT molnartamas outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients